Key facts
- This page summarizes Brian P. McKeon's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 9 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 18 Feb 2025, 21:44.
Brian P. McKeon - 14 Feb 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, CFO and Treasurer
- Issuer ticker
- IDXX
- Reported as of
- 14 Feb 2025
- Net transaction value
- -$252,938
- SEC form
- 4
- Accepted by SEC
- 18 Feb 2025, 21:44:17 UTC
- Prior SEC filing
- 07 Aug 2024
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Brian P. McKeon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian P. McKeon filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 18 Feb 2025.
Change
- Previous filing in this sequence was filed on 07 Aug 2024.
- Current net transaction value: -$252,938.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +252
- Change %
- +0.81%
- Price
- $0.000000
- Shares after
- 31,209
- Date
- 14 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +303
- Change %
- +0.97%
- Price
- $0.000000
- Shares after
- 31,512
- Date
- 14 Feb 2025
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +308
- Change %
- +0.98%
- Price
- $0.000000
- Shares after
- 31,820
- Date
- 14 Feb 2025
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +299
- Change %
- +0.94%
- Price
- $0.000000
- Shares after
- 32,119
- Date
- 14 Feb 2025
- Ownership
- Direct
IDXX
transaction
Common Stock
Tax liability
- Transaction value
- $252,938
- Shares
- -569
- Change %
- -1.8%
- Price
- $444.53
- Shares after
- 31,550
- Date
- 14 Feb 2025
- Ownership
- Direct
IDXX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,050
- Date
- 14 Feb 2025
- Ownership
- by Estony McKeon Family, LLC
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -252
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 252
- Exercise price
- Footnotes
- F2
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -303
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 303
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 303
- Exercise price
- Footnotes
- F3
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -308
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 615
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 308
- Exercise price
- Footnotes
- F4
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -299
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 894
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 299
- Exercise price
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.
Footnote F2
Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
Footnote F3
Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023.
Footnote F4
Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024.
Footnote F5
Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025.